iNTRODUCTiON
Respiratory distress syndrome (RDS) is one of the most common reasons of mortality in neonates. American College of Obstetrics and Gynecology recommended determining the status of fetal lung maturity, in infants with less than 39 weeks of gestational age, to avoid RDS (1) . So, evaluating of fetal lung maturity plays an important role in managing of RDS. There are some tests for evaluating the fetal lung maturity with some advantages and disadvantages. For example, the ratio of sphingomyelin to lecithin is a traditional test for assessing the fetal lung maturity (2) ; but taking the long time to do, being costly, lack of widely access, and none ability to use when meconium or blood stained the amniotic fluid, are its disadvantages. Lamellar bodies are produced by type II pneumacytes in fetal alveolus and secreted to amniotic fluid during respiratory movement. These bodies are similar to platelet and can be assessed by cellular counter instruments easily (3); this diagnostic method, in contrast of previous tests, is faster, simpler and cheaper. Some studies have showed that counting lamellar bodies can be useful in estimation of lung maturity (4) .
In regard to deficiency of neonatal intensive care units (NICU), medical orderly, and specialist and not widely measurement of sphingomyeline to lecithin ratio in Iran, this study was aimed to evaluate the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of amniotic lamellar body in predicting fetal lung maturity.
METHODS
This analytic study was conducted from 2010, April to 2011, February, at AL-Zahra Hospital, the main referral university hospital of Isfahan University of Medical Sciences, Isfahan, Iran. Women with 28-37 weeks of gestational age, who had been decided to terminate their pregnancy, were enrolled in the study.
Fetal anomalies, intra uterine fetal death (IUFD), blood in amniotic fluid, rapture of placenta, and patient dissatisfaction were the exclusion criteria. The study protocol was approved in the Ethics Committee of Isfahan University of Medical Sciences and the consent form was assigned by all participants. The study was registered at ClinicalTrials. gov (Identifier: NCT01463722).
After registering demographic data, based on computer randomized table, 128 women divided into two groups. The amniotic fluid samples were ob-tained by amniocentesis (by Principal investigator) during normal delivery or before rupturing the membrane in cesarean. These samples were sent to the laboratory, as soon as possible; after centrifuging with 500 rounds per minute for 3 minutes, they were placed in the cell counter machine (STKR coulter, Beckman-Coulter™ Company, Fulton, MO).
All patients, who were under 34 weeks of gestational age, received corticosteroid therapy before their delivery due to standard schedule.
The respiratory status of each neonate was determined and recorded at delivery. The diagnosis of immaturity and RDS was based on the following criteria: a) Physical examination findings such as: nasal flaring, retraction, grunting, and tachypnea. b) Needing Oxygen support for more than 24 hours with three chest xray findings.
The optimal cut-off point was assessed with receiver operating characteristic (ROC) curve. The sensitivity, specificity, NPV and PPV were also evaluated.
The outcome assessors were blinded to the results and this study was single blinded.
The maximum sample size, based on the coefficient of confidence, with α = 0.05, P = 0.5 and d = 0.1, was assessed as 98 persons. All statistical analyses were done with SPSS 16 software (version 16, SPSS Inc., Chicago, IL) and the p < 0.05 was determined as the statistical difference level. Independent-t was the used statistical test.
RESULTS
One hundred and twenty eight pregnant women with 131 infants were evaluated. The mean of maternal and gestational ages were 28.12 ± 3.84 years and 32.56 ± 2.72 weeks, respectively. Of 128 pregnancies, 126 women were singleton, one had twins, and one was triple. Fifty two mothers were gravida 1, 48 were gravida 2, 23 were gravida 3, 6 were gravida 4, and 2 were gravida 5.
The mothers' demographic data are shown in table 1. Seventy four newborns have matured lung and 57 were delivered with RDS. The mean of mother's age in immature and matured lung infant were 25.75 ± 3.66 and 28.40 ± 3.89 years, respectively. There was no significant relationship between lung immaturity with maternal age (p = 0.339).
The mean maternal gravity in fetal immature lung group was 1.58 ± 0.39 compared with 1.59 ± 0.59 in fetal maturity lung group. The lung maturity had no significant relationship with mother's gravity (p = 0.551). The gestational age of mothers with matured fetal lung (34.28 ± 1.86 weeks) was significantly higher than mothers with immature lung infant (30.33 ± 1.92 weeks) (p < 0.001).
The mean value of lamellar body was 31266 ± 15831 µl in immature lung infants compared with 63081 ± 16966 µl in matured lung infant (p < 0.001) with a strongly direct correlation between gestational age and lamellar body concentration (r = 0.734, p = 0.001) (Figure 1) .
In ROC curve, the area under-curve the was about 0.923 (r < 0.001) which indicated that lamellar body counting test had a fair accuracy for diagnosis of fetal lung maturity (Figure 2 ).
According to ROC curve, the optimal cut-off point for lamellar body counting was 47500 µl with the sensitivity of 85.1%, specificity of 92.6%, NPV Table 2 . The sensitivity and specificity of amniotic lamellar body in different concentrations of 82.5, and PPV of 92.6 (Table 2 ).
DiSCUSSiON
Our findings indicated that lamellar body counting test has a high confidence value in detecting fetal lung maturity. The sensitivity of 85.1% and specificity of 91.2% showed that this test is suitable for detecting fetal lung maturity.
Rapid and accurate diagnosis of fetal lung maturity in management of high risk pregnancies has an important role to avoid RDS. Lamellar body counting is one of rapid, accurate, and cheap tests which can be useful in detecting fetal lung maturity.
This study showed when lamellar body concentration is 47500 µl, as a cut-off point, the sensitivity, specificity, PPV, and NPV are 85.1%, 91.2%, 92.6%, and 82.5%, respectively. Ashwood et al. reported that lamellar body counting is a suitable test for predicting fetal lung maturity. They also found the optimal cut-off point of 55000 µl for making decision in fetal lung maturity (5). Dalence et al. reported 30000 µl as optimal cut-off point (6) . The differences in the optima cut-off points may be due to the difference in the used centrifuge protocols and counter instruments.
Neerhof et al. (7) showed that centrifuge is not a necessary process for this test and suggested 50000 µl as an optimal cut-off point. They also reported that under the 15000 µl of lamellar body concentration, immaturity of fetal lung existed with 100% sensitivity. The difference between their study and our findings may be due to different methods of lamellar body measurement.
Wijnberger et al. (8) in a meta-analysis mentioned that 32000 µl of concentration is suitable for prediction fetal lung maturity. They indicated that capability of fetal lung maturity prediction with lamellar body counting is equal to sphingomyeline to lecithin ratio test. Therefore, they recommended lamellar body counting test as the first choice for fetal lung maturity assessing. Our findings supported this idea.
We found the NPV of 82.5 % and PPV of 92.6% for the lamellar body counting test. Khazardoost et al. in Tehran, Iran showed NPV of 97% and PPV of 48% and Beinlich et al. showed PPV of 50% and NPV of 90% for this test. These differences probably may be because of differences in sample size, inclusion criteria, or used instruments. The sensitivity in our findings was 85.1% which were similar to other studies (9,10).
CONCLUSiONS
This study indicated that lamellar body counting test has a high PPV with a good sensitivity, specificity, and NPV. Future studies for different cellular counter are warranted. 
